331 related articles for article (PubMed ID: 37982847)
1. Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.
Riedl JM; Moik F; Esterl T; Kostmann SM; Gerger A; Jost PJ
Virchows Arch; 2024 Feb; 484(2):169-179. PubMed ID: 37982847
[TBL] [Abstract][Full Text] [Related]
2. [Personalized medicine in oncology].
Lörsch AM; Jung J; Lange S; Pfarr N; Mogler C; Illert AL
Pathologie (Heidelb); 2024 May; 45(3):180-189. PubMed ID: 38568256
[TBL] [Abstract][Full Text] [Related]
3. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
4. Is Personalized Medicine Here?
Carneiro BA; Costa R; Taxter T; Chandra S; Chae YK; Cristofanilli M; Giles FJ
Oncology (Williston Park); 2016 Apr; 30(4):293-303, 307. PubMed ID: 27085327
[TBL] [Abstract][Full Text] [Related]
5. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
[TBL] [Abstract][Full Text] [Related]
6. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
Miyachi H
Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
[TBL] [Abstract][Full Text] [Related]
7. [Imaging: The oncologist's perspective].
Fuxius S
Radiologe; 2021 Jan; 61(1):6-12. PubMed ID: 33340067
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards.
Fujiwara Y; Kato S; Kurzrock R
Surg Oncol Clin N Am; 2024 Apr; 33(2):197-216. PubMed ID: 38401905
[TBL] [Abstract][Full Text] [Related]
9. Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.
McGowan ML; Settersten RA; Juengst ET; Fishman JR
Urol Oncol; 2014 Feb; 32(2):187-92. PubMed ID: 24445286
[TBL] [Abstract][Full Text] [Related]
10. [Precision oncology and molecular tumor boards].
Mack E; Horak P; Fröhling S; Neubauer A
Inn Med (Heidelb); 2024 May; 65(5):462-471. PubMed ID: 38652307
[TBL] [Abstract][Full Text] [Related]
11. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.
Pfohl U; Pflaume A; Regenbrecht M; Finkler S; Graf Adelmann Q; Reinhard C; Regenbrecht CRA; Wedeken L
Cells; 2021 Apr; 10(4):. PubMed ID: 33920536
[TBL] [Abstract][Full Text] [Related]
12. Pathologists and liquid biopsies: to be or not to be?
Hofman P; Popper HH
Virchows Arch; 2016 Dec; 469(6):601-609. PubMed ID: 27553354
[TBL] [Abstract][Full Text] [Related]
13. [Molecular tumor diagnostics as the driving force behind precision oncology].
Kazdal D; Menzel M; Budczies J; Stenzinger A
Dtsch Med Wochenschr; 2023 Sep; 148(18):1157-1165. PubMed ID: 37657453
[TBL] [Abstract][Full Text] [Related]
14. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
15. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
[TBL] [Abstract][Full Text] [Related]
16. Precision diagnostics: integration of tissue pathology and genomics in cancer.
Sharma S; George P; Waddell N
Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
[TBL] [Abstract][Full Text] [Related]
17. SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics.
Singer F; Irmisch A; Toussaint NC; Grob L; Singer J; Thurnherr T; Beerenwinkel N; Levesque MP; Dummer R; Quagliata L; Rothschild SI; Wicki A; Beisel C; Stekhoven DJ
BMC Med Inform Decis Mak; 2018 Oct; 18(1):89. PubMed ID: 30373609
[TBL] [Abstract][Full Text] [Related]
18. One mouse, one patient paradigm: New avatars of personalized cancer therapy.
Malaney P; Nicosia SV; Davé V
Cancer Lett; 2014 Mar; 344(1):1-12. PubMed ID: 24157811
[TBL] [Abstract][Full Text] [Related]
19. Targeted Therapy and Personalized Medicine.
Saeed RF; Awan UA; Saeed S; Mumtaz S; Akhtar N; Aslam S
Cancer Treat Res; 2023; 185():177-205. PubMed ID: 37306910
[TBL] [Abstract][Full Text] [Related]
20. Benefits of functional assays in personalized cancer medicine: more than just a proof-of-concept.
Morand du Puch CB; Vanderstraete M; Giraud S; Lautrette C; Christou N; Mathonnet M
Theranostics; 2021; 11(19):9538-9556. PubMed ID: 34646385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
